Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
Journal of Virology|May 13, 2021
Dynein Light-Chain Dynlrb2 Is Essential for Murine Leukemia Virus Traffic and Nuclear EntryGianfranco Pietrantoni, Aracelly Gaete-Argel, Diego Herrera-Rojo, et al.Journal of Neurophysiology|January 29, 2010
Differential roles of NMDA Receptor Subtypes NR2A and NR2B in dendritic branch development and requirement of RasGRF1Fernando J Sepulveda, Fernando J Bustos, Eveling Inostroza, et al.Polish Journal of Veterinary Sciences|November 3, 2021
Participation of interferon type I during canine parvovirus infectionT Reyes-Cruz, D Martínez-Gómez, A Verdugo-Rodríguez, et al.Molecular Medicine (Cambridge, Mass.)|October 25, 2024
Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron deathPablo Martínez, Mónica Silva, Sebastián Abarzúa, et al.Biorxiv : the Preprint Server for Biology|June 3, 2024
Skeletal myotubes expressing ALS mutant SOD1 induce pathogenic changes, impair mitochondrial axonal transport, and trigger motoneuron deathPablo Martínez, Mónica Silva, Sebastián Abarzúa, et al.Journal of Chemical Neuroanatomy|May 4, 2019
PSD95 regulates morphological development of adult-born granule neurons in the mouse hippocampusMuriel D Mardones, Patricia V Jorquera, Andrea Herrera-Soto, et al.Frontiers in Veterinary Science|August 28, 2020
Immunogenicity of a Dendrimer B2T Peptide Harboring a T-Cell Epitope From FMDV Non-structural Protein 3DRodrigo Cañas-Arranz, Patricia de León, Mar Forner, et al.NPJ Vaccines|October 6, 2025
Single dose of foot-and-mouth disease peptide vaccine fully protects swine and achieves intraserotype crossed neutralizationEsther Blanco, Elisa Torres, Patricia de León, et al.Biochimica Et Biophysica Acta|May 25, 2016
Polycomb PRC2 complex mediates epigenetic silencing of a critical osteogenic master regulator in the hippocampusRodrigo Aguilar, Fernando J Bustos, Mauricio Saez, et al.European Journal of Medicinal Chemistry|February 16, 2010
Catalytic nanomedicine: a new field in antitumor treatment using supported platinum nanoparticles. In vitro DNA degradation and in vivo tests with C6 animal model on Wistar ratsT López, F Figueras, J Manjarrez, et al.Pageof 9